| Record | OBS-0305 |
|---|---|
| Category | Health/Pandemics |
| Status | PARTIALLY SUBSTANTIATED |
| Summary | Thalidomide was a drug marketed in the late 1950s and early 1960s to treat morning sickness and anxiety, but it caused severe birth defects in thousands of children worldwide. The scandal led to stricter drug regulations and a major legal and financial settlement for victims. |
| Origin | The drug was developed in 1953 by Ciba, acquired by Chemie Grünenthal, and marketed from 1957. The link to birth defects was identified in 1961 by Widukind Lenz and William McBride, leading to its withdrawal. |
| Claimed |
|
| Evidence / consensus | The thalidomide tragedy is a well-documented historical event. It is confirmed that the drug caused birth defects, leading to regulatory changes. However, the extent of corporate culpability and the exact number of affected individuals remain debated. |
Sources are external and provided for verification. Listing does not imply the Observer endorses their claims.